Skip to main content
Cynthia Dunbar, MD, Hematology, Bethesda, MD

CynthiaElizabethDunbarMD

Hematology • Bethesda, MD

Physician

Join to view full profile

Dr. Dunbar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Dunbar's full profile

Already have an account?

  • Office

    5132 Rockville Pike
    Rm 4E
    Bethesda, MD 20892
    Phone+1 301-496-5093
    Fax+1 301-594-1290

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1984 - 1987
  • Harvard Medical School
    Harvard Medical SchoolClass of 1984

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1989 - 2026
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2003

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • An All Antibody Approach for Conditioning Bone Marrow for Hematopoietic Stem Cell Transplantation with Anti-cKIT and Anti-CD47 in Non-Human Primates
    Cynthia E. Dunbar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome(MDS) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Modeling Human Paroxysmal Nocturnal Hemoglobinuria Via CRISPR/Cas9 HSPC Gene Editing in Non-Human Primate 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Gene Therapy for Rare Brain Disease Effective, but Comes with Blood Cancer Risk
    Gene Therapy for Rare Brain Disease Effective, but Comes with Blood Cancer RiskOctober 9th, 2024
  • High-Dose MTX Does Not Reduce CNS Relapse in Pediatric ALL
    High-Dose MTX Does Not Reduce CNS Relapse in Pediatric ALLDecember 11th, 2022
  • Ash 2022 – Argenx Faces Vyvgart Questions
    Ash 2022 – Argenx Faces Vyvgart QuestionsDecember 10th, 2022
  • Join now to see all

Grant Support

  • The Rhesus Macaque As A Preclinical Model For Induced Pluripotent Stem CellsNational Heart, Lung, And Blood Institute2010–2011
  • Retroviral Mediated Gene Transfer Into Primate Hematopoietic CellsNational Heart, Lung, And Blood Institute2010–2011
  • Enhancement Of Hematopoietic Stem Cell Mobilization And EngraftmentNational Heart, Lung, And Blood Institute2010–2011
  • Developing Efficient And SAFE Gene Transfer To Primate Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2010–2011
  • Gene Transfer And Ex Vivo Manipulation Of Stem CellsNational Heart, Lung, And Blood Institute2009
  • Gene Transfer And Ex Vivo Manipulation Of Hematopoietic CellsNational Heart, Lung, And Blood Institute1998–2008
  • Gene Transfer And Ex Vivo Manipulation Of HematopoieticNational Heart, Lung, And Blood Institute2001–2006
  • Gene Transfer To Hematopoietic Progenitor, Stem, And Stromal CellsNational Heart, Lung, And Blood Institute1995–1997
  • Gene Transfer To Human Hematopoietic Progenitor, Stem, And Stromal CellsNational Heart, Lung, And Blood Institute1994
  • Preclinical And Clinical Gene Transfer To Human Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1992–1993

Dr. Cynthia Dunbar, Dr. Cynthia Dunbar, MD, Dr. C Dunbar, Dr. Cynthia Elizabeth Dunbar